30 reports

Cardiovascular diseases accounts for highest patient pool in the country, after HIV/ AIDS.

  • General Medicine And Specialty Medicine
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Teleflex Incorporated
  • 4.1 BIBLIOGRAPHY

EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL (ECDC) (2017) HIV/ AIDS SURVEILLANCE IN EUROPE 2017.

  • Epidemiology
  • General Medicine And Specialty Medicine
  • Japan
  • United States
  • Forecast

ABBOTT MAINLY FOCUSES ON SIX CORE THERAPEUTIC AREAS SUCH RHEUMATOID ARTHRITIS, HIV/ AIDS, RESPIRATORY INFECTIONS, CANCER, DIABETES AND GENETIC CONDITIONS.

  • General Medicine And Specialty Medicine
  • World
  • Market Size
  • CareDx, Inc.
  • Illumina, Inc.

(USA) ##.

  • General Medicine And Specialty Medicine
  • Europe
  • United States
  • World
  • Market Shares

ENVA. ##) in Healthy, HIV- ## Uninfected Adults (Ad##.

  • General Medicine And Specialty Medicine
  • Infectious Disease
  • Therapy
  • Transplantation
  • Chimerix, Inc.

GOVERNMENT S INITIATIVE TO DELIVER LIFE-SAVING SERVICES AND IMPROVE THE LIVES OF THOSE LIVING WITH HIV/ AIDS AROUND THE WORLD.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Influenza
  • Interventional Cardiology Device
  • Endologix, Inc.

## ## ## ## Merck & Co Inc ## ## ## ## ## Groupe Francophone des Myelodysplasies ## ## ## ## ## Daiichi Sankyo Co Ltd ## ## ## ## ## CTI BioPharma Corp ## ## ## ## ## Celerion Inc ## ## ## ## ## Bristol-Myers Squibb C

  • Chemotherapy
  • General Medicine And Specialty Medicine
  • Leukemia
  • Therapy
  • Celgene Corporation

The prominent features of this report are - ##.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Lymphoma
  • United States
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Drug Development
  • General Medicine And Specialty Medicine
  • Transplantation
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Leukemia
  • Novartis AG
  • Clinical Trial Profile Snapshots
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • General Medicine And Specialty Medicine
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • World

## ## ## ## ## ## ## ## Jazz Pharmaceuticals Plc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Bristol-Myers Squibb Co ## ## ## ## ## ## ## ## AbbVie Inc ## ## ## ## ##

  • General Medicine And Specialty Medicine
  • Lymphoma
  • Transplantation
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • General Medicine And Specialty Medicine
  • Targeted Therapy
  • World
  • Product Initiative
  • Celgene Corporation

The prominent features of this report are - ##.

  • Blood Disease
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Leukemia
  • Novartis AG

The prominent features of this report are - ##.

  • Cancer
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Leukemia
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Liver Transplant
  • Transplantation
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Monoclonal Antibody
  • Transplantation
  • Novartis AG

## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## Sarah Cannon Research Institute LLC ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ##

  • Cancer
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Heart Transplant
  • Pharmaceutical
  • Novartis AG
  • Clinical Trial profile. 39 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cell Therapy
  • General Medicine And Specialty Medicine
  • Therapy
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## Canada Source: GlobalData' s Phar

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Medical Biotechnology
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Neopharm Ltd ## ## ## ## ## ## ## ## Mallinckrodt Plc ## ## ## ## ## ## ## ## Bellicum Pharmaceutic

  • Drug Development
  • General Medicine And Specialty Medicine
  • Pharmaceutical
  • Transplantation
  • World

Food And Drug Administration (FDA) an application for orphan drug designation for the use of PRO ## (humanized monoclonal antibody to CCR##) in the pretreatment of HIV Type-## (HIV-##) infection in treatment-naive adults.

  • General Medicine And Specialty Medicine
  • Healthcare
  • Medical Biotechnology
  • Transplantation
  • United States

## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma Intellige

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Leukemia
  • Monoclonal Antibody
  • Novartis AG

The prominent features of this report are - ##.

  • Drug Development
  • General Medicine And Specialty Medicine
  • United States
  • World
  • Product Initiative

AS ONLY HIV PATIENTS WHO copy HIV-## research test.

  • General Medicine And Specialty Medicine
  • Healthcare
  • Medical Biotechnology
  • United States
  • Product Initiative

PRO ## belongs to a new class of HIV/ AIDS therapeutics -- viral-entry inhibitors -- that are intended to protect healthy cells from viral infection.

  • Cell Therapy
  • General Medicine And Specialty Medicine
  • Specialty Hospital
  • Transplantation
  • Pluristem Therapeutics Inc.

PRO ## belongs to a new class of HIV/ AIDS therapeutics -- viral-entry inhibitors -- that are intended to protect healthy cells from viral infection.

  • General Medicine And Specialty Medicine
  • Healthcare
  • Medical Biotechnology
  • United States
  • Product Initiative
  • GRAFT VERSUS HOST DISEASE (GVHD) - PIPELINE BY GILEAD SCIENCES INC
  • BONE MARROW TRANSPLANT REJECTION - PIPELINE BY GILEAD SCIENCES INC

The company offers products in various therapeutic areas including cardiovascular, respiratory, inflammation, liver diseases, cancer and HIV/ AIDS.

  • Cell Therapy
  • General Medicine And Specialty Medicine
  • Healthcare
  • Transplantation
  • Product Initiative

IN ITS MOST RECENTLY PUBLISHED DATA, THE CENTERS FOR DISEASE CONTROL AND PREVENTION ESTIMATES OVER ##. ## MILLION PEOPLE ARE LIVING WITH HIV/ AIDS IN THE U. S.

  • General Medicine And Specialty Medicine
  • Northern Europe
  • United Kingdom
  • Forecast
  • Market Size